Immunic reported 0 in Sales Revenues for its fiscal quarter ending in June of 2024.





Sales Change Date
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
BioMarin Pharmaceutical USD 1.03B 40M Sep/2026
Cipla INR 74.04B 2.85B Sep/2026
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 2.6M 3.75M Jun/2026
CSL USD 8.33B 4.79B Dec/2025
Enanta Pharmaceuticals USD 16.96M 50.68M Dec/2024
Grifols EUR 2B 306.7M Mar/2026
Insmed USD 524.42M 98.93M Sep/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Quidel USD 618.9M 12M Sep/2026
Ultragenyx Pharmaceutical USD 173M 41M Sep/2026
United Therapeutics USD 832.5M 49.2M Sep/2026